Le Floc’h et al at Regeneron generated an anti-common gamma chain monoclonal that blocks signaling.

"Treatment of nonhuman primates with REGN7257 suppressed NK cells and T cells without affecting granulocytes, erythrocytes, or platelets."

https://www.science.org/doi/10.1126/scitranslmed.abo0205